Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond
Jonathan Corren, Christopher E. Brightling, Louis-Philippe Boulet, Celeste Porsbjerg, Michael E. Wechsler, Andrew Menzies-Gow, Christopher S. Ambrose, Bill Cook, Neil Martin, Joseph Spahn, Jean-Pierre Llanos
European Respiratory Journal Mar 2023, 61 (3) 2202202; DOI: 10.1183/13993003.02202-2022